Entheon Biomedical Corp (ENBI.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 11/30
| 05-2024 | 02-2024 | 11-2023 | 08-2023 | 05-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 299 | 250 | 345 | 382 | 479 |
| Marketable Securities | N/A | N/A | N/A | 0 | 8 |
| Receivables | 4 | 6 | 6 | 11 | 7 |
| TOTAL | $330 | $287 | $396 | $421 | $549 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 5 | 5 | 5 | 10 | 25 |
| TOTAL | $5 | $5 | $5 | $10 | $25 |
| Total Assets | $335 | $292 | $401 | $431 | $574 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | N/A | 51 | 85 | 42 | 89 |
| TOTAL | $42 | $51 | $85 | $42 | $89 |
| Non-Current Liabilities | |||||
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $42 | $51 | $85 | $42 | $89 |
| Shareholders' Equity | |||||
| Common Shares | 20,061 | 19,961 | 19,961 | 19,354 | 19,354 |
| Retained earnings | -21,478 | -21,383 | -21,308 | -20,628 | -20,533 |
| Other shareholders' equity | 1,710 | 1,663 | 1,663 | 1,663 | 1,665 |
| TOTAL | $294 | $241 | $316 | $389 | $485 |
| Total Liabilities And Equity | $335 | $292 | $401 | $431 | $574 |